Stiftung Tierärztliche Hochschule Hannover (TiHo)

Recombinant influenza A viruses as vaccine vectors

Gerlach, Thomas; Elbahesh, Husni ORCID; Saletti, Giulietta VIAF; Rimmelzwaan, Guus F. GND

INTRODUCTION:Various viruses, including poxviruses, adenoviruses and vesicular stomatitis virus, have been considered as vaccine vectors for the delivery of antigens of interest in the development of vaccines against newly emerging pathogens. AREAS COVERED:Here, we review results that have been obtained with influenza A viruses (IAV) as vaccine vectors. With the advent of reverse genetics technology, IAV-based recombinant vaccine candidates have been constructed that induce protective immunity to a variety of different pathogens of interest, including West Nile virus, Plasmodium falciparum and respiratory syncytial virus. The various cloning strategies to produce effective and attenuated, safe to use IAV-based viral vectors are discussed. EXPERT COMMENTARY:It was concluded that IAV-based vector system has several advantages and holds promise for further development.

Cite

Citation style:
Gerlach, T., Elbahesh, H., Saletti, G., Rimmelzwaan, G.F., 2019. Recombinant influenza A viruses as vaccine vectors. Expert review of vaccines 18, 379–392. https://doi.org/10.1080/14760584.2019.1582338
Could not load citation form. Default citation form is displayed.

Rights

Use and reproduction:
All rights reserved

Export